University of Virginia
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 37
- Registration Number
- NCT03401047
- Locations
- 🇺🇸
University of Virginia Clinical Research Unit, Charlottesville, Virginia, United States
Mechanistic Clinical Trial of Advanced Imaging for CRT
- Conditions
- Heart Failure, Systolic
- Interventions
- Diagnostic Test: CMR/CTA Guidance for CRT
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2020-02-06
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 180
- Registration Number
- NCT03398369
- Locations
- 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States
Exercise Activity-Based Bolus Decisions in Type 1 Diabetes
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Other: Activity on BoardOther: Usual Diabetes Care
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2018-05-23
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 15
- Registration Number
- NCT03394352
- Locations
- 🇺🇸
University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States
NEO Rehab for Infants at Risk of Cerebral Palsy
- Conditions
- PrematurityCerebral Palsy
- Interventions
- Other: Standard of careOther: NICU-based rehabilitation bundle
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 14
- Registration Number
- NCT03372590
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Device: Dexcom CGM G5Device: Continuous Subcutaneous Insulin Infusion
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 48
- Registration Number
- NCT03369067
- Locations
- 🇺🇸
Barbara Davis Center, University of Colorado, Aurora, Colorado, United States
🇺🇸University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States
🇺🇸Stanford University, Stanford, California, United States
A Pilot Test of t:Slim X2 With Control-IQ Technology
- Conditions
- Type1 Diabetes Mellitus
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2022-05-25
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 5
- Registration Number
- NCT03368937
- Locations
- 🇺🇸
University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
- Conditions
- CirrhosisAdrenal InsufficiencySpur Cell AnemiaLecithin Acyltransferase Deficiency
- Interventions
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 100
- Registration Number
- NCT03368066
- Locations
- 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States
Phase I EGFR BATs in Newly Diagnosed Glioblastoma
- Conditions
- GlioblastomaGlioblastoma Multiforme
- Interventions
- Drug: Weekly EGFR BATs following SOC RT/TMZDrug: EGFR BATs with TMZ following SOC RT/TMZ
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 16
- Registration Number
- NCT03344250
- Locations
- 🇺🇸
Samantha Brooks, Charlottesville, Virginia, United States
Colonoscopy in the Prone Position for Patients With BMI Greater Than 30
- Conditions
- Obesity
- Interventions
- Procedure: Position during colonoscopy
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2019-06-12
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 141
- Registration Number
- NCT03337217
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Hyperpolarized Xenon-129 MRI (Experimental)
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 30
- Registration Number
- NCT03331302
- Locations
- 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States